top of page

EPI GUIDE: Use of Long-Acting Injectable Antipsychotics

EPI Canada clinical guidance documents provide clinicians with evidence-based recommendations for the diagnosis, assessment, and management of psychosis. This guidance is developed by an expert panel of clinicians who evaluate the available literature and develop consensus-based recommendations.

Authors: Phil Tibbo, MD FRCPC (chair); Howard Margolese, MD, MSc, FRCPC; Marc-André Roy, MD, MSc, FRCP

This initiative has been sponsored in part by Teva Canada through an educational grant.

Canadian Consortium for

Early Intervention in Psychosis

Hamilton, ON

905-525-8213

Contact Us: admin@epicanada.org​

Become a Friend of EPI Canada!

bottom of page